ZN-A-1041 was designed to be blood-brain-barrier-penetrant, and has the potential to treat or prevent the onset of brain metastases in patients with HER2-positive metastatic breast cancer
EIP Pharma to initiate in 2Q 2023 a Phase 2b clinical study, funded in part by a $21 million grant from the National Institute of Aging
The agreement is for USFDA approved Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate Tablets
With digitally available health records, individuals can avail paper-less health services under Ayushman Bharat Digital Mission (ABDM)
N-nitroso dimethylamine (NDMA) is a probable human carcinogen and tts effects on humans rely on observational studies.
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
The term of O&M is for 15 years with a lock in period of 5 years for the Company and 15 years for VHPL & Bharathi Education trust.
This digital linking of individual’s health records with ABHA is being carried out extensively across different health facilities of the country
LG Chem will receive totaling up to $95.5 million for the China rights
The current ruling will assure the safety of the use of Ranitidine for Indian patients
Subscribe To Our Newsletter & Stay Updated
